Michele De Tursi
- Internal Medicine top 1%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 14
- Colorectal Cancer Treatments and Studies 9
- HER2/EGFR in Cancer Research 8
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 7
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 6
- Emergency Medical Services top 2%
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Nicola TinariClara NatoliEttore PorrecaMarcello Di NisioAntonino GrassadoniaStefano IacobelliPietro Di MarinoHarry R. Büller
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Michele De Tursi
57 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Internal Medicine 340
- Oncology 576
- Cancer Research 304
- Emergency Medical Services 138
- Cardiology and Cardiovascular Medicine 244
Countries citing papers authored by Michele De Tursi
This map shows the geographic impact of Michele De Tursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele De Tursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele De Tursi more than expected).
Fields of papers citing papers by Michele De Tursi
This network shows the impact of papers produced by Michele De Tursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele De Tursi. The network helps show where Michele De Tursi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michele De Tursi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 24 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 31 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 26 | |
| 11 | 2019 | 21 | |
| 12 | 2019 | 124 | |
| 13 | 2018 | 4 | |
| 14 | 2018 | 1 | |
| 15 | 2015 | 135 | |
| 16 | 2014 | 7 | |
| 17 | 2014 | 12 | |
| 18 | 2012 | 19 | |
| 19 | 2010 | 76 | |
| 20 | 2007 | 10 |
About Michele De Tursi
Michele De Tursi is a scholar working on Oncology, Internal Medicine and Cancer Research, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Genomics and Diagnostics (7 papers), Lung Cancer Research Studies (7 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Internal Medicine (340 citations), Oncology (576 citations) and Cancer Research (304 citations). Michele De Tursi has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Nicola Tinari, Clara Natoli, Ettore Porreca, Marcello Di Nisio, Antonino Grassadonia, Stefano Iacobelli, Pietro Di Marino, Harry R. Büller, Patrizia Vici and Davide Brocco. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancers, Journal of Thoracic Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.